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INTRODUCTION
Carcinomas of the EBD are uncommon neoplasms that
are morphologically heterogeneous, and associated
with poor prognosis.1 Invasive Papillary Carcinomas
(PC) of the EBD represent 4-5% of all malignant
epithelial tumours of this region, and appear to have a
much less aggressive clinical course. Non-invasive and
minimally invasive papillary carcinomas of EBD are
even rarer, behave as carcinoma in-situ, and are
associated with excellent long-term prognosis
regardless of their cytological features, or their
immunoreactivity for p53 and MIB 1.2,3 Hence,
separation of invasive from non-invasive or minimally
invasive papillary carcinoma is critical in estimating the
patient outcome.1 We report a case of minimally
invasive papillary carcinoma of the EBD in a 55-year-old
gentleman.
These tumours should be distinguished from biliary
papillomatosis, intraductal papillary mucinous carci-
noma of the pancreas extending into the bile ducts,
papillary adenoma and papillary hyperplasia.2
CASE REPORT
A 55-year-old previously healthy male presented with
complaints of lethargy, weight loss, anorexia and
epigastric pain for 2 months. On general physical
examination, he was jaundiced and rest of the
examination was unremarkable. Laboratory investi-
gations revealed deranged liver function tests.
The values were total bilirubin at 4.9 mg/dl, direct
bilirubin at 2.7 mg/dl, indirect bilirubin at 2.2 mg/dl,
gamma GT at 580 iu/L, SGPT at 180 iu/L and alkaline
phosphatase at 471 iu/L.
Abdominal ultrasound revealed dilated common bile-
duct (1.8 cm in diameter) and intrahepatic bile ducts.
However, no definite obstructing mass was identified.
Computed Tomography (CT) of the abdomen showed
an enhancing irregular mass in the distal common bile
duct, which measured 2.2 x 2.1 x 1.8 cm. It was causing
proximal dilatation of intrahepatic duct, the cystic duct
and the gallbladder. A possibility of cholangiocarcinoma
was raised. Endoscopic Retrograde Cholangio-
pancreatography (ERCP) and biopsy were
recommended for further evaluation. However, as the
CT clearly showed the mass in distal common bile duct,
those were not performed and a Whipple’s procedure,
with an intraoperative frozen section was done.
Peroperatively, there was no ascites or evidence of
peritoneal, pelvic or hepatic disease. A polypoidal
tumour was seen localized to the distal Common Bile
Duct (CBD) and cystic duct. Proximal CBD was tumour-
free. Part of the tumour was sent for frozen section on
which a diagnosis of a papillary neoplasm was given.
Pancreaticoduodenectomy was performed. The
specimen was received in the section of histopathology
coded as “Whipple’s specimen with omentum”. It
comprised of the distal stomach, proximal small
intestine, gallbladder with dilated common bile duct
(CBD) and the head of pancreas. On opening the
stomach and small intestine, the mucosa was
unremarkable. The gallbladder was separated from the
CBD, which measured 5 x 1.2 cm. On further sectioning
the CBD, an exophytic, polypoidal, intraluminal whitish
mass was identified obstructing the lumen
(Figure 1). The lesion was 1.8 cm in the largest diameter
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extending upto the pancreatic duct. However, it was not
grossly invading the wall. Multiple sections of the tumour
along with the wall of the CBD were taken and submitted
for microscopic evaluation. Nine lymph nodes were
recovered from the specimen, all of which were
submitted entirely.
A second container labeled as ‘common hepatic artery
lymph nodes’ was also sent, from which four lymph
nodes were recovered and all were submitted entirely
for histopathological evaluation.
Histologic sections from the CBD lesion revealed a
neoplasm exhibiting an exophytic proliferation of
complex papillary structures into the lumen of the bile
duct. Variably-sized, finger-like epithelial processes
lined by pseudostratified columnar cells showing
vesicular nuclei and prominent nucleoli were observed.
Mitotic figures were appreciated (approximately 3-4/10
HPF).
A single focus of superficial invasion was seen in one
section (Figure 2). No other focus of infiltration was seen
in the entirely submitted specimen.
A diagnosis of ‘extra hepatic bile duct papillary
carcinoma with minimal invasion’ was given. The
proximal gastric, distal duodenal and pancreatic
resection margins were tumour-free. The omentum was
not involved by the tumour. The 9 lymph nodes
recovered from the main specimen as well as the 4
common hepatic artery lymph nodes were all tumour-
free. The tumour was staged as Tis, No, Mx.     
The patient was stable postoperatively. LFT’s became
normal. He experienced mild nausea and was tolerating
liquids and soft food quite well. He was discharged on
antibiotics and analgesics. Currently, he is doing well.
Chemotherapy along with radiation is planned.
DISCUSSION
Despite their simple histological structure, the extra-
hepatic bile ducts give rise to a group of morphologically
heterogenous malignant epithelial neoplasms.
These tumours usually occur in older individuals with an
average age of 68.4 years. Incidence is almost equal in
either gender. Most patients present with obstructive
jaundice, weight loss, elevated serum bilirubin, and right
upper quadrant pain. Majority i.e. 49% of the cases
occur in the upper third or hilar area, 25% in the middle
third, and 19% in the lower third. Diffuse involvement
occurs in 7% of the cases. Risk factors include primary
sclerosing cholangitis, choledochal cyst, an anomalous
pancreaticobiliary junction with reflux, cholelithiasis,
gallbladder carcinoma, infection with liver flukes, and
use of oral contraceptives.3
Most cancers of the EBD give rise to early symptoms
because of obstruction. These tumours have a relatively
poor prognosis. This is thought to be attributable in part
to rapid infiltration of the tumour into the thin walls of the
EBD and invasion into the periductal connective tissue,
which is rich in vessels and nerves.4
Microscopically, the large majority of bile duct
malignancies are well differentiated, mucin producing
adenocarcinomas.5
Representing a small proportion (4-5%) of all malignant
epithelial tumours of the EBD, that is 4-5%, papillary
carcinomas tend to grow into the lumen, and only late in
their course do they invade the ductal wall and
periductal tissue. Because of this feature, they follow a
protracted clinical course and appear to be associated
with a better prognosis than conventional adenocarci-
nomas of EBD.2
Papillary carcinomas of the EBD can be classified as
invasive and non-invasive. This separation is important
because non-invasive and minimally invasive papillary
carcinomas behave as in-situ carcinomas. Invasion of full
thickness of the ductal wall and beyond appears to be
the most significant prognostic factor.1
Saavedra et al. clearly demonstrated that the non-
invasive and minimally invasive carcinoma of EBD,
regardless of their cytological features, p53 and MIB 1
reactivity, are associated with an excellent long-term
prognosis.2 In this study, none of the patients developed
recurrence or metastasis. The excellent prognosis of
papillary carcinomas is in sharp contrast with the poor 5-
year survival rate of the most common conventional
adenocarcinomas of EBD and, therefore, warrants
histological distinction. 
The 5-year and 10-year relative survival rates for 71
patients with invasive papillary carcinoma, confined to
the ductal wall, were found to be 28% and 21% in
comparison to 18% and 12% for those with conventional
adenocarcinoma respectively.1
The presence and location of the tumours are best
shown by retrograde endoscopic cholangiography
(ERCP), or percutaneous transhepatic cholangiography.
Using the latter technique, the site of extrahepatic
obstruction can be demonstrated in 95% of the cases.6,7
Surgical resection offers the only possibility of cure for
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Figure 1: Exophytic, polypoidal,
intraluminal whitish mass
obstructing the lumen.
Figure 2: Intraluminal tumour with a
single focus of invasion (H+E x 20).
bile duct carcinoma. Proximal lesions are treated with
resection (which may include hepatic lobectomy) and
Roux-en-Y hepaticojejunostomy; distal lesions are
treated by Whipple’s procedure. A modest improvement
in the results has been obtained with combined modality
approach consisting of surgery, radiation therapy and
chemotherapy. Location, histological grade, and
histological type are the most important prognostic
indicators.8,9
A variety of lesions of the EBD that show papillary
architecture should be distinguished from papillary
carcinoma, including papillomatosis, papillary or villous
adenomas, primary papillary hyperplasia, and intraduct
papillary mucinous neoplasms of the pancreas. Biliary
papillomatosis is a multicentric disease that leads to
multiple filling defects in several areas of the EBD, or the
entire extrahepatic biliary tree. It is associated with a
high rate of recurrence and poor prognosis. Malignant
transformation occurs in 25% of the cases. In contrast,
papillary carcinoma forms discrete, well-defined
polypoidal lesion that obstructs the lumen of a single
EBD. Papillary or villous adenomas show a less
complex architecture, dysplastic changes are less
pronounced. However, in adenomas, which show
marked dysplasia, mitotic figures and some cribriforming
are extremely difficult to differentiate from papillary
carcinoma, especially in small biopsy sample. Primary
biliary hyperplasia of the gallbladder may also involve
the cystic duct, or CBD. However, there is no cytological
atypia in these cases. Intraduct papillary mucinous
carcinoma of pancreas may extend into the ampulla of
Vater and CBD, simulating non-invasive papillary
carcinoma. However, these tumours are usually
multifocal, and produce abundant extracellular mucin,
features that are lacking in these papillary carcinomas.2
Because the non-invasive and minimally invasive
papillary carcinomas behave as non-metastasizing, or
in-situ carcinomas, a conservative surgical approach
such as segmental resection with frozen section of the
surgical margins should be considered in select cases.
Extension of the tumour into the surgical margins is a
powerful adverse prognostic factor, and a predictor of
local recurrence.2
It is important to separate invasive papillary carcinomas
of the EBD from non-invasive and minimally invasive
carcinomas as they behave as in-situ carcinomas and
are associated with an excellent prognosis as compared
to conventional adenocarcinomas of the EBD.
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